Geriatria

Diretriz sobre prevenção da ulceração do pé em pacientes diabéticos.

18 Jul, 2022 | 13:28h

Australian guideline on prevention of foot ulceration: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease – Journal of Foot and Ankle Research

Conteúdos relacionados:

Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease – Journal of Foot and Ankle Research

Australian guideline on management of diabetes-related foot infection: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease – Journal of Foot and Ankle Research

Australian guideline on wound classification of diabetes-related foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Australian guideline on wound healing interventions to enhance healing of foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Australian guideline on offloading treatment for foot ulcers: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease

Guideline: ADA 2022 Standards of Medical Care in Diabetes.

NICE Updated Guidance: Management of Type 2 Diabetes.

Recent updates to clinical practice guidelines for diabetes mellitus.

Position Statement: a disease state approach to the pharmacological management of type 2 diabetes in primary care.

 

---

Estudo de coorte baseado em registro | Fatores de risco modificáveis e não modificáveis na mortalidade da fratura de quadril na Noruega, 2014 a 2018.

18 Jul, 2022 | 13:17h

Modifiable and non-modifiable risk factors in hip fracture mortality in Norway, 2014 to 2018 – The Bone & Joint Journal

 

---

Evidências e fontes da Cochrane Library | Úlceras de pressão.

18 Jul, 2022 | 13:05h

Pressure ulcers (pressure injuries): evidence and resources – Evidently Cochrane

 

---

M-A | Oxigênio domiciliar para hipoxemia moderada na doença pulmonar obstrutiva crônica.

14 Jul, 2022 | 11:58h

Home oxygen for moderate hypoxaemia in chronic obstructive pulmonary disease: a systematic review and meta-analysis – The Lancet Respiratory Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

Home oxygen probably makes little or no difference to 3-year mortality in pts with #COPD and moderate hypoxaemia

Systematic review & meta-analysis from Yves Lacasse & colleagues https://t.co/8wDrkEd1LH pic.twitter.com/UoOqW7hngT

— The Lancet Respiratory Medicine (@LancetRespirMed) July 11, 2022

 

---

Estudo de coorte | Risco e tempo de cirurgia não cardíaca após implante de válvula aórtica transcateter.

14 Jul, 2022 | 11:55h

Risk and Timing of Noncardiac Surgery After Transcatheter Aortic Valve Implantation – JAMA Network Open

Comentários:

Surgery After TAVR: Waiting a Month or More Not Really Better— Prosthesis-patient mismatch, paravalvular regurgitation the bigger issues for surgical candidates – MedPage Today (necessário cadastro gratuito)

Patients can safely undergo noncardiac surgeries after TAVR without a long delay – Cardiovascular Business

 

Comentários no Twitter

In this cohort study, noncardiac surgery (NS) after transcatheter aortic valve implantation (TAVI) was not associated with more perioperative adverse events. Suboptimal device performance was associated with increased risk of adverse outcomes after NS. https://t.co/OYSLECeOzt

— JAMA Network Open (@JAMANetworkOpen) July 7, 2022

Interesting analysis of 300 pts undergoing NCS after TAVI: NCS may be performed early (<30d) after successful TAVI. Suboptimal device performance (prosthesis-pt mismatch, paravalvular regurg) was associated with incr risk
Risk and Timing of NCS After TAVI https://t.co/ILS3YBFcyz

— Steven Cohn, MD (@preopconsult) July 10, 2022

 

---

Diretriz de consenso ESC | Telemedicina em idosos para prevenção e tratamento de doenças cardiovasculares e fragilidade.

14 Jul, 2022 | 11:54h

Digital health in older adults for the prevention and management of cardiovascular diseases and frailty. A clinical consensus statement from the ESC Council for Cardiology Practice/Taskforce on Geriatric Cardiology, the ESC Digital Health Committee and the ESC Working Group on e-Cardiology – ESC Heart Failure

 

---

M-A | Fatores correlacionados a função física 1 ano após artroplastia total de joelho em pacientes com osteoartrite de joelho.

13 Jul, 2022 | 12:06h

Factors Correlated With Physical Function 1 Year After Total Knee Arthroplasty in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis – JAMA Network Open

 

Comentário no Twitter

This meta-analysis of 20 prospective cohort studies (11,317 patients) found associations between presurgical BMI, physical function, and osteoarthritis severity and physical function after total knee arthroplasty (TKA). https://t.co/tQf7HytTEW

— JAMA Network Open (@JAMANetworkOpen) July 11, 2022

 

---

European Medicines Agency recomenda reforço de vacina contra COVID em pessoas com mais de 60 anos.

12 Jul, 2022 | 11:54h

European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Guidance – Health Policy Watch

 

---

M-A | Pouco benefício da viscossuplementação na osteoartrose de joelho.

12 Jul, 2022 | 11:52h

Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis – The BMJ

Comunicado de imprensa: Scant evidence to recommend use of hyaluronic acid injections for knee osteoarthritis – BMJ Newsroom

Comentário: Common injections don’t help knee osteoarthritis more than placebo, large data review finds – STAT

 

Comentário no Twitter

New research finds that injections of hyaluronic acid to treat knee osteoarthritis make almost no difference to pain and might raise risk of adverse events https://t.co/G80BHoOgl3

— The BMJ (@bmj_latest) July 7, 2022

 

---

Análise secundária de um estudo randomizado | Duração da terapia antiplaquetária após intervenção coronariana percutânea complexa em pacientes sob alto risco de sangramento.

12 Jul, 2022 | 11:29h

Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis – European Heart Journal

Comentários:

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity – CardiovascularNews

One-Month DAPT Enough for Complex PCI if Bleeding Risk High – Medscape (necessário cadastro gratuito)

 

Comentário no Twitter

Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis https://t.co/0FX0Exj8sh @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/Ac8h0AkL42

— European Society of Cardiology Journals (@ESC_Journals) May 31, 2022

 

---